National Cancer Institute; Notice of Closed Meetings, 81834 [2015-32935]
Download as PDF
<![CDATA[
81834
Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices
and Research Support Awards., National
Institutes of Health, HHS)
Dated: December 28, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32941 Filed 12–30–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant and contract
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant and contract applications, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SBIR
Targeted Radiation Therapy.
Date: January 27, 2016.
Time: 10:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate contract
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W538, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Ivan Ding, MD, Scientific
Review Officer, Special Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W412, Bethesda, MD 20892–
9750, 240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Physical
Sciences-Oncology Projects.
Date: February 9–10, 2016.
Time: 6:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree by Hilton Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Research and
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W266, Bethesda, MD 20892,
240–276–6385, lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
I-Transition to Independence.
VerDate Sep<11>2014
16:49 Dec 30, 2015
Jkt 238001
Date: February 23–24, 2016.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Tushar Baran Deb, Ph.D.,
Scientific Review Officer, Research and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W624, Rockville, MD 20850, 240–
276–6132 tushar.deb@nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
J—Career Development.
Date: March 2–3, 2016.
Time: 6:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, Suites 6711,
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Robert E. Bird, Ph.D.,
Scientific Review Officer, Research and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W110, Bethesda, MD 20892, 240–
276–6344, birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–1.
Date: March 3–4, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree by Hilton Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Bethesda, MD
20892, 240–276–6372, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Diagnosis.
Date: April 4–5, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Bratin K. Saha, Ph.D.,
Program Coordination & Referral Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W556, Rockville, MD 20850,
240–276–6411, sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Questions Review—PQ 12.
Date: April 6, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W126, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Caron A. Lyman, Ph.D.,
Chief, Scientific Review Officer, Research
Program Review Branch, Division of
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W126, Bethesda, MD 20892–9750,
240–276–6348, lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 28, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32935 Filed 12–30–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Drug
Abuse.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: February 10, 2016.
Closed: 8:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Open: 10:30 a.m. to 4:00 p.m.
E:\FR\FM\31DEN1.SGM
31DEN1
]]>Agencies
[Federal Register Volume 80, Number 251 (Thursday, December 31, 2015)]
[Notices]
[Page 81834]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32935]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant and contract applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant and contract
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SBIR Targeted Radiation Therapy.
Date: January 27, 2016.
Time: 10:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate contract applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Ivan Ding, MD, Scientific Review Officer,
Special Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W412,
Bethesda, MD 20892-9750, 240-276-6444, dingi@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Physical Sciences-Oncology Projects.
Date: February 9-10, 2016.
Time: 6:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree by Hilton Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Officer, Research and Technology and Contract Review Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W266, Bethesda, MD 20892, 240-276-
6385, lovingeg@mail.nih.gov.
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee I-Transition to Independence.
Date: February 23-24, 2016.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Tushar Baran Deb, Ph.D., Scientific Review
Officer, Research and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W624, Rockville, MD 20850, 240-276-6132
tushar.deb@nih.gov.
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee J--Career Development.
Date: March 2-3, 2016.
Time: 6:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, Suites 6711, Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Robert E. Bird, Ph.D., Scientific Review
Officer, Research and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Bethesda, MD 20892, 240-276-6344,
birdr@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus R03 & R21 SEP-1.
Date: March 3-4, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree by Hilton Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Bethesda, MD 20892, 240-276-6372, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Diagnosis.
Date: April 4-5, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Bratin K. Saha, Ph.D., Program Coordination &
Referral Branch, Division of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive, Room 7W556, Rockville, MD
20850, 240-276-6411, sahab@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Provocative Questions Review--PQ 12.
Date: April 6, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W126, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review
Officer, Research Program Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-6348,
lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 28, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32935 Filed 12-30-15; 8:45 am]
BILLING CODE 4140-01-P
